Roche's Half|Year Results 2024 Presentation

Roche's Half-Year Results 2024 Presentation

Access the Roche webcast replay of the Virtual Hematology Investor Event.

Half-Year Report 2024 | Roche

Accordingly from 1 January 2024 the results of the Foundation Medicine business are reported as part of the Diagnostics Division, and the ...

Invitation to Roche's Half Year Results 2024 Presentation - Marktpuls

Roche will publish its Half Year Results of 2024 prior to the opening of the Swiss Stock Exchange on Thursday, 25 July 2024. ... The webinar will start with ...

F. Hoffmann-La Roche Announces Half Year Results 2024 | News

F. Hoffmann-La Roche Ltd. (hereafter “Roche”) [Head office: Basel, Switzerland. CEO: Thomas Schinecker] announced today its half year results 2024.

Roche Holding RHHBY Q2 2024 Earnings Presentation - YouTube

Dive into the Q2 2024 earnings presentation accompanied by the full earnings conference call, providing you with a complete understanding of ...

Reminder: Invitation to Roche's Half Year Results 2024 Presentation

Reminder: Invitation to Roche's Half Year Results 2024 Presentation | RHHBY - Roche Holding Ltd.

F. Hoffmann-La Roche Announces Half Year Results 2024 | News

Name of listed company: Chugai Pharmaceutical Co., Ltd. Code number: 4519 (Prime Market of Tokyo Stock Exchange). Head office:.

Invitation to Roche's Half Year Results 2024 Presentation | RHHBY

Invitation to Roche's Half Year Results 2024 Presentation | RHHBY - Roche Holding Ltd.

Roche Holding AG (RHHBY) Q2 2024 Earnings Call Transcript

We've had a very strong growth in the first half year. Group sales increased by 8%, excluding COVID by 8 -- by 5%, excluding COVID by 8%.

Invitation to Roche's Half Year Results 2024 Presentation - Public now

Roche Holding AG. 06/25/2024 | Press release | Distributed by Public on 06/25/2024 10:02. Invitation to Roche's Half Year Results 2024 Presentation ...

[Ad hoc announcement pursuant to Art. 53 LR] Roche sales

[Ad hoc announcement pursuant to Art. 53 LR] Roche sales increase by 5% (CER) in first half of 2024; strong growth in second quarter – full-year ...

Roche Holding AG (RHHBY) Q3 2024 Sales/Trading Statement Call

Now year-to-date group sales are at plus 6% at constant exchange rates really driven by a strong base business growth of 8%. The COVID ...

Novartis quarterly financial results

Novartis quarterly financial results, including media releases and year-to-date figures ... Novartis quarterly financial results. Q3 2024; Q2 2024; Q1 2024 ...

Results and presentations - AstraZeneca

Latest results announcements and presentations · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 ...